Discuva
Discuva is a company dedicated to developing innovative solutions in the field of microbiology and infectious diseases. Their mission is to advance research and provide effective tools to combat microbial threats, aiming to improve health outcomes worldwide.
Industries
biotechnology
genetics
health-care
pharmaceutical
Nr. of Employees
small (1-50)
Discuva
Patents
Products
Ivonescimab (SMT112)
A bispecific antibody for oncology, targeting PD-1 and VEGF to potentially treat non-small cell lung cancer and other solid tumors.
Phase III Clinical Trials
Advanced stage trials for Ivonescimab in non-small cell lung cancer and other solid tumors, with over 1,600 patients treated in studies.
Ivonescimab (SMT112)
A bispecific antibody for oncology, targeting PD-1 and VEGF to potentially treat non-small cell lung cancer and other solid tumors.
Phase III Clinical Trials
Advanced stage trials for Ivonescimab in non-small cell lung cancer and other solid tumors, with over 1,600 patients treated in studies.